Overview
One-liner
Programmable DNA drug destroying all cancers, unlocking 80% of targets
Why it's interesting
Market trends shaping FinalDose
- 1GLP-1 dominance reshaping cardiometabolic and obesity pipelines
- 2Cell and gene therapy manufacturing finally industrializing
- 3Targeted protein degraders attracting record biotech megarounds
- 4Psychedelics moving toward first FDA approvals in PTSD and depression
- 5RNA and mRNA platforms expanding beyond infectious disease
- 6China-originated assets fueling US pharma BD at record pace
Insights · email required
Unlock the 6 trends behind FinalDose
Enter your email to read every market insight across all 400 startups — free.
Recommended reading & listening
Related insights & creators
- Mar 2026 · neweconomies.coLongevity: Can Ageing Be Reversed?
Mapping 115+ startups helping us live longer.
- Newsletter · new-media.coOutlive Health
Longevity, diagnostics, and the new consumer health stack.
- Mar 2026 · neweconomies.coAI Infrastructure Boom: GPT-5.4, $500M Chips, Brain Implants
$230M brain-implant bet, OpenAI's new model, Netflix's AI acquisition.
- Newsletter · Podcast · new-media.coFitt Insider
The business of fitness, health, and wellness consumer brands.